Anzueto A et al. |
Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group. |
1998 Sep-Oct |
Clin Ther |
pmid:9829441
|
Howden CW and Hunt RH |
Treating Helicobacter pylori. |
1998 |
Arch. Intern. Med. |
pmid:9827792
|
Ward TT et al. |
Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium. |
1998 |
Clin. Infect. Dis. |
pmid:9827282
|
Kaeser YA et al. |
Severe hypotension and bradycardia associated with verapamil and clarithromycin. |
1998 |
Am J Health Syst Pharm |
pmid:9825040
|
Laine L et al. |
Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials. |
1998 |
Am. J. Gastroenterol. |
pmid:9820381
|
Murata H et al. |
Evaluation of the PyloriTek test for detection of Helicobacter pylori infection in cases with and without eradication therapy. |
1998 |
Am. J. Gastroenterol. |
pmid:9820380
|
Mermelstein HT |
Clarithromycin-induced delirium in a general hospital. |
1998 Nov-Dec |
Psychosomatics |
pmid:9819955
|
Champney WS and Burdine R |
Macrolide antibiotic inhibition of translation and 50S ribosomal subunit assembly in methicillin-resistant Staphylococcus aureus cells. |
1998 |
Microb. Drug Resist. |
pmid:9818968
|
Vrioni G et al. |
Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin. |
1998 |
J. Antimicrob. Chemother. |
pmid:9818747
|
Cirioni O et al. |
In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii. |
1998 |
J. Antimicrob. Chemother. |
pmid:9818742
|
Arimori K et al. |
Characteristic difference in gastrointestinal excretion of clarithromycin and roxithromycin. |
1998 |
Biopharm Drug Dispos |
pmid:9818709
|
Björkholm B et al. |
Rapid PCR detection of Helicobacter pylori-associated virulence and resistance genes directly from gastric biopsy material. |
1998 |
J. Clin. Microbiol. |
pmid:9817898
|
Clark CL et al. |
Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies. |
1998 |
J. Clin. Microbiol. |
pmid:9817876
|
Miehlke S et al. |
Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection. |
1998 Nov-Dec |
Digestion |
pmid:9813387
|
Abouesh A and Hobbs WR |
Clarithromycin-induced mania. |
1998 |
Am J Psychiatry |
pmid:9812131
|
Fabry W et al. |
Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium tuberculosis. |
1995 |
Zentralbl. Bakteriol. |
pmid:9810662
|
Hynes B |
Contact granulomas. |
1998 |
J Otolaryngol |
pmid:9800633
|
Bortolotti M et al. |
Effects of oral clarithromycin and amoxycillin on interdigestive gastrointestinal motility of patients with functional dyspepsia and Helicobacter pylori gastritis. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9798808
|
Spadaccini A et al. |
Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9798805
|
Cestari R |
Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection. H. Pylori Lombardy Group. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9798804
|